Insmed reported $807.32M in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
DBV Technologies DBVT:US 0 0
Acelrx Pharmaceuticals ACRX:US $ 9.89M 1.97M
Alimera Sciences ALIM:US $ 43.8M 0.2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Cytokinetics CYTK:US $ 199.42M 1.44M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Heron Therapeutics HRTX:US $ 149.18M 0.05M
Insmed INSM:US $ 807.32M 534K
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NVS:US $ 31031M 244M
Ophthotech OPHT:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M